🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was awarded for transformative discoveries that clarify how the immune system targets dangerous pathogens while sparing the healthy tissues.

Three renowned scientists—Japan's Shimon Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—share this accolade.

Their research identified specialized "sentinels" within the defense system that remove malfunctioning immune cells that could attacking the organism.

These findings are now paving the way for innovative therapies for immune disorders and malignancies.

The winners will share a monetary award worth 11 million Swedish kronor.

Decisive Discoveries

"Their work has been essential for comprehending how the immune system functions and the reason we do not all develop serious self-attack conditions," stated the head of the award panel.

The trio's research explain a core mystery: How does the immune system protect us from countless invaders while keeping our healthy cells intact?

The body's protection system employs white blood cells that search for indicators of infection, including viruses and bacteria it has never encountered.

These cells employ detectors—known as recognition units—that are generated randomly in countless combinations.

This provides the defense network the capacity to combat a wide array of threats, but the unpredictability of the mechanism inevitably creates white blood cells that may attack the host.

Protectors of the Body

Researchers previously knew that a portion of these problematic defense cells were eliminated in the immune organ—where white blood cells mature.

This year's award recognizes the discovery of T-reg cells—known as the body's "peacekeepers"—which patrol the system to disarm other immune cells that assault the healthy cells.

We know that this process malfunctions in autoimmune diseases such as juvenile diabetes, MS, and RA.

A Nobel panel added, "The discoveries have established a new field of investigation and spurred the creation of innovative treatments, for instance for tumors and immune disorders."

In cancer, T-regs prevent the body from fighting the growth, so studies are focused on lowering their numbers.

For self-attack disorders, experiments are exploring increasing T-reg cells so the body is not under attack. A similar approach could also be useful in minimizing the risks of organ transplant failure.

Pioneering Experiments

Professor Sakaguchi, from a Japanese institution, performed tests on rodents that had their immune gland removed, causing autoimmune disease.

He demonstrated that introducing defense cells from healthy animals could stop the illness—implying there was a mechanism for blocking defenders from harming the host.

Mary Brunkow, from the a research center in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an genetic autoimmune disease in rodents and humans that led to the identification of a gene critical for the way regulatory T-cells operate.

"The pioneering research has uncovered how the immune system is kept in check by regulatory T cells, preventing it from accidentally targeting the healthy cells," commented a prominent physiology expert.

"The research is a striking illustration of how fundamental physiological study can have broad consequences for human health."